Haemonetics Corp. buy BTIG Research
Start price
10.09.24
/
50%
€66.50
Target price
10.09.25
€101.52
Performance (%)
-32.03%
End price
11.09.25
€45.20
Summary
This prediction ended on 11.09.25 with a price of €45.20. The BUY prediction by BTIG_Research for Haemonetics Corp. performed very badly with a performance of -32.03%. BTIG_Research has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | - | - | - |
| iShares Core DAX® | -0.917% | -2.585% | 21.603% |
| iShares Nasdaq 100 | -3.301% | 1.620% | 11.248% |
| iShares Nikkei 225® | -4.194% | 4.289% | 18.788% |
| iShares S&P 500 | -1.866% | 0.992% | 6.273% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten